Press Releases Items Per Page 102550 Year None2023202220212020201920182017201620152012 Mar 10, 2023 Galera Announces Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology View HTML PDF Version Mar 08, 2023 Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates View HTML PDF Version Feb 15, 2023 Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants View HTML PDF Version Feb 15, 2023 Galera Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis View HTML PDF Version results
